Form D Summary: Lifemine Therapeutics $5.03 million Financing. Gregory L Verdine Published Oct 6 Form D

Pharmaceuticals Lifemine Therapeutics, Inc. - Gregory L Verdine

Lifemine Therapeutics Financing

Lifemine Therapeutics, Inc., Corporation just filed form D announcing $5.03 million equity and debt financing. This is a new filing. Lifemine Therapeutics was able to sell $5.00 million. That is 99.50% of the fundraising offer. The total private offering amount was $5.03 million. This form was filed on 2016-10-06. The reason for the financing was: unspecified. The fundraising still has about $25,000 more and is not closed yet. We have to wait more to see if the offering will be fully taken.

Lifemine Therapeutics is based in Massachusetts. The company’s business is Pharmaceuticals. The D form was filed by Gregory L Verdine President. The company was incorporated in 2016. The filler’s address is: 245 First Street, 18Th Fl., Suite 1802, Cambridge, Ma, Massachusetts, 02142. Gregory L. Verdine is the related person in the form and it has address: C/O Lifemine Therapeutics, Inc., 245 First Street, 18Th Fl., Suite 1802, Cambridge, Ma, Massachusetts, 02142. Link to Lifemine Therapeutics Filing: 000168695516000001.

Analysis of Lifemine Therapeutics Offering

On average, firms in the Pharmaceuticals sector, sell 60.90% of the total offering size. Lifemine Therapeutics sold 99.50% of the offering. The fundraising is still open. Could this mean that the trust in Lifemine Therapeutics is high? The average fundraising size for companies in the Pharmaceuticals industry is $556,000. The total amount raised is 799.37% bigger than the average for companies in the Pharmaceuticals sector. The minimum investment for this fundraising is set at $0. If you know more about the reasons for the fundraising, please comment below.

What is Form D? What It Is Used For

Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.

Why Fundraising Reporting Is Good For Lifemine Therapeutics Also

The Form D signed by Gregory L Verdine might help Lifemine Therapeutics, Inc.’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment